000 | 01964 a2200577 4500 | ||
---|---|---|---|
005 | 20250518065742.0 | ||
264 | 0 | _c20201029 | |
008 | 202010s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/s41598-019-52141-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKufareva, Irina | |
245 | 0 | 0 |
_aDiscovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors. _h[electronic resource] |
260 |
_bScientific reports _c11 2019 |
||
300 |
_a15893 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aCasein Kinase II _xantagonists & inhibitors |
650 | 0 | 4 | _aCatalytic Domain |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 |
_aHoloenzymes _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 |
_aPeptides _xchemistry |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
650 | 0 | 4 |
_aProtein Subunits _xantagonists & inhibitors |
650 | 0 | 4 | _aSubstrate Specificity |
650 | 0 | 4 | _aSurface Plasmon Resonance |
700 | 1 | _aBestgen, Benoit | |
700 | 1 | _aBrear, Paul | |
700 | 1 | _aPrudent, Renaud | |
700 | 1 | _aLaudet, Béatrice | |
700 | 1 | _aMoucadel, Virginie | |
700 | 1 | _aEttaoussi, Mohamed | |
700 | 1 | _aSautel, Celine F | |
700 | 1 | _aKrimm, Isabelle | |
700 | 1 | _aEngel, Matthias | |
700 | 1 | _aFilhol, Odile | |
700 | 1 | _aBorgne, Marc Le | |
700 | 1 | _aLomberget, Thierry | |
700 | 1 | _aCochet, Claude | |
700 | 1 | _aAbagyan, Ruben | |
773 | 0 |
_tScientific reports _gvol. 9 _gno. 1 _gp. 15893 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-019-52141-5 _zAvailable from publisher's website |
999 |
_c30272652 _d30272652 |